Our lungs are amazing, quietly doing their thing to keep us breathing and alive. But when they are compromised by disease, ...

In the Phase 3 VISIONARY study, sibeprenlimab achieved a statistically significant and clinically meaningful 51.2% (P<0.0001) reduction in proteinuria at nine months of treatment when compared to ...

Through this Phase 2 TB drug combination trial, BioVersys and its partner GSK seek to get further insights of the potential impact of AlpE in TB patient’ treatments. Under the GSK-BioVersys ...

Tuberculosis cavitation is a complex phenotype driven by biochemical, biophysical, immunological, and microbiological processes that have important roles during the different stages of cavitation ...

Greenland, JC ∙ Cutting, E ∙ Kadyan, S ∙ et al. Azathioprine immunosuppression and disease modification in Parkinson's disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial ...

Many people with tuberculosis stay in the latent infection stage, but some develop the active disease. Both stages are treatable. Tuberculosis (TB) is a bacterial infection that usually affects ...